We have previously confirmed the presence of common antigens between Schistosoma mansoni and its vector, Biomphalaria glabrata. Cross-reactive antigens may be important as possible candidates for vaccine and diagnosis of schistosomiasis. Sera from outbred mice immunized with a soluble Biomphalaria glabrata antigen (SBgA) of non-infected B. glabrata snails recognized molecules of SBgA itself and S. mansoni AWA by Western blot. Recognition of several molecules of the SBgA were inhibited by pre-incubation with AWA (16, 30, 36, 60 and 155 kDa). The only specific molecule of AWA, inhibited by SBgA, was a 120 kDa protein. In order to determine which epitopes of SBgA were glycoproteins, the antigen was treated with sodium metaperiodate and compared with non-treated antigen. Molecules of 140, 60 and 24 kDa in the SBgA appear to be glycoproteins. Possible protective effects of the SBgA were evaluated immunizing outbred mice in two different experiments using Freund's Adjuvant. In the first one (12 mice/group), we obtained a significant level of protection (46%) in the total worm load, with a high variability in worm recovery. In the second experiment (22 mice/group), no significant protection was observed, neither in worm load nor in egg production per female. Our results suggest that SBgA constitutes a rich source of candidate antigens for diagnosis and prophylactic studies.

Severe schistosomiasis is a rare event in Venezuela nowadays, after a successful national campaign by the Schistosomiasis Control Program. Unfortunately, this program has practically disappeared, and snail surveillance in field is not a priority, anymore. Thus, schistosomiasis has become a neglected disease in this country. However, surveys in different populations from the endemic area have shown particular epidemiological features described herein. In five communities we evaluated 2,175 persons and searched for the presence of Biomphalaria glabrata snails. Some markers were used for classifying schistosomiasis foci: mean age of the persons with Schistosoma mansoni eggs in the stools, serological tests, presence of B. glabrata snails, and intensity of infection. Places without B. glabrata snails and with few schistosomiasis cases were defined as "past transmission sites"; a site with abundant snails but few cases was defined as "potential risk"; "new transmission" foci were characterized by the presence of infected snails and young people passing eggs in the stools. A "re-emergent" focus has shared these last features, showing in addition a place where schistosomiasis had been reported before. Recent evidences of active transmission with the increasing dispersion of B. glabrata snails, point out the necessity for the re-establishment of the Schistosomiasis Control Program in Venezuela.

Schistosomiasis control seems to be different in countries were low parasitic burden and asymptomatic clinical patients are the features of majority of cases. Immunological methods must substitute the traditional coprologic techniques used for some decades in the Control Program. Circumoval Precipitin Test (COPT), intradermal test and ELISA with soluble egg antigen (SEA) are evaluated for using as tools for seroepidemiologic studies. COPT and ELISA were performed after treatment to known their utility when impact of chemotherapy must be assessed. One hundred sixty five persons were followed up 3, 6, 9 and 12 months after treatment. The mean sensitivity of CPT studied by age groups was 95.6% which is very important considering that 88.4% of the studied population excreted less than 100 egg/gr of feces, while sensitivity of intradermal test was 58.2%. Children showed the highest ractivity to COPT. When treatment is effective, COPT reactivity progressively disminish until become negative one year later. In the non cure group, the COPT reactivity disminished but never below 20%. ELISA-SEA did not modify one year after treatment. Effort should be made to isolate fractions of eggs Schistosoma mansoni whose antibodies disappear after treatment.

The number and pattern of argentophilic papillae (chaetotaxy) of Schistosoma mansoni cercariae, permits the differentiation between the male and the female of this larval stage, through the following criteria: - A greater homogenity in the male cercariae concerning the number of ventral and dorsal papillae on the body and tail (C.V.= 4.1%), than in the female cercariae (C.V.=18.3%) (p<0.001). - The presence in the 80% of the male cercariae of papillae on the inferior-right and left quadrant, respectively, on the ventral surface; while this criterion is only present in the 40% of the female cercariae (P<0.001). A significative statistical difference (P<0.001) between the average number of ventral body papillae in the female cercariae (X =11.9 ± 0.2) and the male cercariae (X = 11.1 ± 0.3). -A significative statistical difference (p<0.05) for the average of the major distance between the papillae AIL-AIIL for each cercariae in relation to the sex (men = 25.5 µm, women = 27.3 µm).

El número de papilas argirófilas superficiales y su modelo de disposición en el tegumento de las cercarias (quetotaxia) de Schistosoma mansoni nos permitió diferenciar los sexos a nivel del mencionado estadío larvario, mediante los siguientes critérios: - Mayor homogeneidad en las cercarias machos, en cuanto al número total de papilas ventrales y dorsales a nivel de cuerpo y cola cercarianos (C.V. = 4,1%), que en las cercarias hembras (C. V. = 18,3%) (P < 0,001). - Presencia en el 80% de las cercarias machos de cuatro papilas en los cuadrantes "C" ó "D" )inferior-izquierdo e inferior-derecho, respectivamente) ventrales, mientras que dicho caracter sólo está presente en el 40% de las cercarias hembras (P < 0,001). - Diferencia estadísticamente significativa (P < 0,001) entre el número total promedio de papilas corporales centrales de las cercarias hembras (X = 11,9 ± 0,2) y el de las cercarias machos (X = 11,1 ± 0,3). - Diferencia estadísticamente significativa (P < 0,05) para la mayor distancia promedio entre las papilas AIL y AIIL, de cada cercaria, en relación con el sexo (femenino = 25,5 µm ± 0,33; masculino = 27,3 µm ± 0,26).